| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22248-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22363-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22001-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21734-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-14570-500ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-14609-500ul | |||
![Western Blot: EBI3 Antibody (SR1394) [NBP3-22248] - Western blot analysis using NBP3-22248 in K562 cell lysate.](http://images.novusbio.com/fullsize/nbp3-22248_rabbit-ebi3-mab-sr1394-57202315584817.jpg "Western Blot: EBI3 Antibody (SR1394) [NBP3-22248] - Western blot analysis using NBP3-22248 in K562 cell lysate.")
![Western Blot: Serpin G1/C1 Inhibitor Antibody (SR1022) [NBP3-22363] - Western blot analysis using NBP3-22363 in Human plasma lysate.](http://images.novusbio.com/fullsize/nbp3-22363_rabbit-serpin-g1-c1-inhibitor-mab-sr1022-572023178468.jpg "Western Blot: Serpin G1/C1 Inhibitor Antibody (SR1022) [NBP3-22363] - Western blot analysis using NBP3-22363 in Human plasma lysate.")
![Western Blot: SNRPD1 Antibody - BSA Free [NBP3-45873] - HEK-293 cells were subjected to SDS PAGE followed by western blot with (SNRPD1 antibody) at dilution of 1:500](http://images.novusbio.com/fullsize/nbp3-45873_rabbit-snrpd1-pab-bsa-free-28420251372077.jpg "Western Blot: SNRPD1 Antibody - BSA Free [NBP3-45873] - HEK-293 cells were subjected to SDS PAGE followed by western blot with (SNRPD1 antibody) at dilution of 1:500")
![Western Blot: MIF Antibody (S05-8H5) [NBP3-19690] - Western blot detection of MIF in C6, 3T3 cell lysates using NBP3-19690 (1:1000 diluted). Predicted band size: 13kDa. Observed band size: 13kDa.](http://images.novusbio.com/fullsize/MIF-Antibody-S05-8H5-Western-Blot-NBP3-19690-img0001.jpg "Western Blot: MIF Antibody (S05-8H5) [NBP3-19690] - Western blot detection of MIF in C6, 3T3 cell lysates using NBP3-19690 (1:1000 diluted). Predicted band size: 13kDa. Observed band size: 13kDa.")
![Western Blot: Kininogen 1 Antibody (SR2002) [NBP3-22001] - Western blot analysis using NBP3-22001 in Human platelet lysate.](http://images.novusbio.com/fullsize/nbp3-22001_rabbit-kininogen-1-mab-sr2002-5720231524624.jpg "Western Blot: Kininogen 1 Antibody (SR2002) [NBP3-22001] - Western blot analysis using NBP3-22001 in Human platelet lysate.")
![Western Blot: Serpin A9/Centerin Antibody (SR1815) [NBP3-21734] - Western blot analysis using NBP3-21734 in MCF7 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21734_rabbit-serpin-a9-centerin-mab-sr1815-672023106276.jpg "Western Blot: Serpin A9/Centerin Antibody (SR1815) [NBP3-21734] - Western blot analysis using NBP3-21734 in MCF7 cell lysate.")
![Western Blot: NLRP3/NALP3 Antibody (S07-9E9) [NBP3-20025] - Western blot detection of NLRP3/NALP3 in THP-1 cell lysates using NBP3-20025 (1:1000 diluted). Predicted band size: 118KDa. Observed band size: 118KDa.](http://images.novusbio.com/fullsize/NLRP3-NALP3-Antibody-S07-9E9-Western-Blot-NBP3-20025-img0001.jpg "Western Blot: NLRP3/NALP3 Antibody (S07-9E9) [NBP3-20025] - Western blot detection of NLRP3/NALP3 in THP-1 cell lysates using NBP3-20025 (1:1000 diluted). Predicted band size: 118KDa. Observed band size: 118KDa.")
![Flow Cytometry: IFN-gamma Antibody (B-B1) [NBP3-14570] - The graph on the left represents activated lymphocytes marked with IFN-gamma antibody. The graph represents activated lymphocytes marked with IFN-gamma antibody. The graph on the right shows IFN-gamma antibody with non-activated lymphocytes. In the two cases, the dotted line represents the IgG1 isotype control.](http://images.novusbio.com/fullsize/IFN-gamma-Antibody-B-B1-Flow-Cytometry-NBP3-14570-img0001.jpg "Flow Cytometry: IFN-gamma Antibody (B-B1) [NBP3-14570] - The graph on the left represents activated lymphocytes marked with IFN-gamma antibody. The graph represents activated lymphocytes marked with IFN-gamma antibody. The graph on the right shows IFN-gamma antibody with non-activated lymphocytes. In the two cases, the dotted line represents the IgG1 isotype control.")
![Western Blot: CD63 Antibody (TS63) - Azide and BSA Free [NBP3-14609] - 1,3 10^5 HEL cells were lysed (lysis buffer containing 1% Brij97 or triton) Migration SDS/page 5-15% gel under non-reducing conditions.](http://images.novusbio.com/fullsize/CD63-Antibody-TS63-Azide-and-BSA-Free-Western-Blot-NBP3-14609-img0001.jpg "Western Blot: CD63 Antibody (TS63) - Azide and BSA Free [NBP3-14609] - 1,3 10^5 HEL cells were lysed (lysis buffer containing 1% Brij97 or triton) Migration SDS/page 5-15% gel under non-reducing conditions.")
![Immunohistochemistry: NALP6 Antibody (Clint-1) [NBP3-11675] - Immunohistochemical staining of bioptic sections of small intestine using NALP6 antibody (Clint-1) at 1:500 dilution. Method: A) Epithelial tissues which express NALP6 (positive control) (black arrows) and connective tissues which do not express NALP6 (negative control) (red arrows) are stained using Clint-1. B) Control confirming non-reactive specificity of the secondary antibody without Clint-1.](http://images.novusbio.com/fullsize/NALP6-Antibody-Clint-1-Immunohistochemistry-NBP3-11675-img0001.jpg "Immunohistochemistry: NALP6 Antibody (Clint-1) [NBP3-11675] - Immunohistochemical staining of bioptic sections of small intestine using NALP6 antibody (Clint-1) at 1:500 dilution. Method: A) Epithelial tissues which express NALP6 (positive control) (black arrows) and connective tissues which do not express NALP6 (negative control) (red arrows) are stained using Clint-1. B) Control confirming non-reactive specificity of the secondary antibody without Clint-1.")